article Open AccessTop 1% cited

CRISPR–Cas12-based detection of SARS-CoV-2

Nature Biotechnology · 2020 · Vol. 38(7) · pp. 870–874

James P. Broughton✉(Mammoth Biosciences (United States))Xianding Deng(University of California, San Francisco)Guixia Yu(University of California, San Francisco)Clare L. Fasching(Mammoth Biosciences (United States))Venice Servellita(University of California, San Francisco)Jasmeet Singh(Mammoth Biosciences (United States))Xin Miao(Mammoth Biosciences (United States))Jessica Streithorst(University of California, San Francisco)Andrea Granados(University of California, San Francisco)Alicia Sotomayor-González(University of California, San Francisco)Kelsey C. Zorn(University of California, San Francisco)Allan Gopez(University of California, San Francisco)Elaine Hsu(University of California, San Francisco)Wei Gu(University of California, San Francisco)Steve Miller(University of California, San Francisco)Chao‐Yang Pan(California Department of Public Health)Hugo Guevara(California Department of Public Health)Debra A. Wadford(California Department of Public Health)Janice S. Chen(Mammoth Hospital)Charles Y. Chiu(University of California, San Francisco)

View via DOI Full-text PDF

CRISPR and Genetic Engineering SARS-CoV-2 and COVID-19 Research Mosquito-borne diseases and controlOutbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)CRISPRBetacoronavirusPandemic2019-20 coronavirus outbreakMedicineInfection control

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2COVID-19 VaccinesCOVID-19 TestingRNA, Guide, CRISPR-Cas SystemsHumansPneumonia, ViralTime FactorsRNA, Guide, KinetoplastidaCoronavirus InfectionsClinical Laboratory TechniquesNucleic Acid Amplification TechniquesPandemicsCRISPR-Cas Systems

Funding

Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Charles and Helen Schwab Foundation
National Institutes of Health
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases

Citations

2,715

FWCI

166.28

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Coronavirus Disease 2019–COVID-19